AI assistant
Sending…
Rua Bioscience Limited — Share Issue/Capital Change 2026
May 21, 2026
66262_rns_2026-05-21_c2209873-f490-4bb2-a572-a38acc152c87.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
RUA
BIOSCIENCE
Capital Change Notice
| Section 1: Issuer information | |
|---|---|
| Name of issuer | Rua Bioscience Limited |
| NZX ticker code | RUA |
| Class of financial product | Ordinary shares |
| ISIN (If unknown, check on NZX website) | NZRUAE0004S1 |
| Currency | NZ$ |
| Section 2: Capital change details | |
| Number issued/acquired/redeemed | 1,400,000 ordinary shares |
| Nominal value (if any) | N/A |
| Issue/acquisition/redemption price per security | $0.00 |
| Nature of the payment (for example, cash or other consideration) | Zero cash – provision of $0 options to CEO |
| Amount paid up (if not in full) | N/A |
| Percentage of total class of Financial Products issued/acquired/redeemed/ (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence)¹ | Rua currently has 338,041,705 ordinary shares on issue and 5,926,673 warrants on issue. This issue of ordinary shares represents 0.41% of the total ordinary shares plus warrants on issue (being the percentage should all warrants vest and be exercised). |
| For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date) | Issue of Options at a Nill Issue and Exercise Price for ordinary shares which rank equally with all other fully paid ordinary shares. |
| Reason for issue/acquisition/redemption and specific authority for issue/acquisition/redemption/ (the reason for change must be identified here) | Placement of new ordinary shares to CEO as part of a long-term incentive plan. |
| Total number of Financial Products of the Class after the issue/acquisition/redemption/Conversion (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue/acquisition/redemption. | Total ordinary shares on issue: 339,441,705 ordinary shares |
| Total warrants on issue: 5,926,673 warrants | |
| In the case of an acquisition of shares, whether those shares are to be held as treasury stock | N/A |
| Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made | Agreement with Board and Listing Rule 4.6.1 |
¹ The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.
| Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements) | Issue of Options at a Nill Issue and Exercise Price for ordinary shares which rank equally with all other fully paid ordinary shares |
|---|---|
| Date of issue/acquisition/redemption | 21/05/2026 |
| Section 3: Authority for this announcement and contact person | |
| Name of person authorised to make this announcement | Paul Naske |
| Contact person for this announcement | Paul Naske |
| Contact phone number | 021 445 154 |
| Contact email address | [email protected] |
| Date of release through MAP | 21/05/2026 |
More from Rua Bioscience Limited
Director's Dealing
2026
May 22
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 12
Interim / Quarterly Report
2026
Feb 26
Director's Dealing
2026
Jan 20
Major Shareholding Notification
2026
Jan 20
Director's Dealing
2026
Jan 19
Director's Dealing
2026
Jan 19
Major Shareholding Notification
2026
Jan 15
Share Issue/Capital Change
2025
Dec 19